Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.11.09.765290

Identification and localization of bone marrow ILC2s using Id2/Cxcr6 dual-reporter mice

Abstract

Type 2 innate lymphoid cells (ILC2s) are present in the bone marrow, where their identification and spatial localization remain challenging because of their low abundance and the expression of shared markers by other lymphoid populations. Here, we evaluated the use of Id2YFP/+ Cxcr6GFP/+ dual-reporter mice to identify and visualize bone marrow ILC2s. Using spectral flow cytometry, we showed that both ST2- and ST2 ILC2s expressed high levels of ID2, whereas CXCR6 expression differed between these subsets. However, the ID2 expressing compartments also contained NK cells, NKT cells, conventional T cells and ILC progenitors. Surface marker profiling identified CD25 and ICOS as useful markers for enriching ILC2 populations, with ST2 enabling the segregation of the ST2- and ST2 subsets. Single-cell RNA sequencing further characterized the diversity of Id2 and Cxcr6 expressing lymphoid populations and supported the use of CD5 and NKp46 as exclusion markers. Combining these markers with the dual-reporter system, confocal microscopy revealed YFPGFPCD5-NKp46- cells compatible with an ILC2 phenotype, distributed throughout the bone marrow as isolated cells or within multicellular clusters. Complementary flow cytometric analyses demonstrated that ILC2s accounted for more than 90% of a phenotypically related reporter-positive population after exclusion of major T and NK cell populations, providing additional support for the identification of the cells visualized in situ as putative ILC2s. Together, these findings establish a strategy combining dual-reporter mice, flow cytometry, transcriptomic profiling and confocal imaging to investigate the localization and spatial organization of putative bone marrow ILC2s.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lepetit, C., Hedde, P., Jacquemin, G., Gomez-Perdiguero, E., Mancini, S. J., GOLUB, R.. 2026-11-10. Identification and localization of bone marrow ILC2s using Id2/Cxcr6 dual-reporter mice. https://doi.org/10.64898/2026.11.09.765290

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗

The antagonism of sex chromosomes and sex hormones dictates outcomes in Th17 cell-mediated central nervous system autoimmunity.

Biological sex traits are shaped by the combined effects of both sex hormones and chromosomes. How these factors interact in sex-related autoimmune diseases, such as multiple sclerosis (MS), has been a subject of intense recent interest. Here, using the Four Core Genotype (FCG) mouse model, in which these two variables can be disentangled, we describe an antagonism between sex hormones and chromosomes that potently influences outcomes in T helper 17 (Th17)-driven progressive central nervous system (CNS) autoimmunity. Male gonadal hormones dampen disease severity, irrespective of sex chromosome complement, by promoting a Wnt/{beta}-catenin signaling program associated with a homeostatic, non-pathogenic Th17 phenotype. By contrast, XY chromosomal complement exacerbates Th17 pathogenicity in a recipient sex-dependent manner; we identify the X-linked molecule SUV39H1 as an inhibitor of inflammatory Th17 cell function. Unexpectedly, we found that hormonally and chromosomally female FCG Th17 cells induced far more severe disease than WT female counterparts despite being genetically identical, pointing to a parental imprinting effect in dictating Th17 cell pathogenicity. These latter investigations uncovered Runx2, a transcription factor previously linked to developmental programs, as a novel negative regulator of the pathogenicity of Th17 cells. Together, our findings establish biological sex as a multilayered regulator of Th17 pathogenicity, revealing distinct and sometimes opposing contributions of hormones, chromosomes, and parental inheritance.

immunology↗